IPRIPR2018-01424Final Written Decision
Eli Lilly and Companyv.Teva Pharmaceuticals International GmbH et al.
IPR challenge of US 9346881.
Type
IPR
Filed
Aug 8, 2018
Instituted
Feb 19, 2019
Decided
—
Patent
Application
14841440
Inventor
Joerg Zeller et al
Granted
May 24, 2016
01
Timeline
3 milestones
2018-08-08Petition filed
2019-02-19Institution
2020-02-18Terminated
02
Parties & counsel
Petitioner
Eli Lilly and Company
Counsel
Raich, Williamet al
Patent Owner
Teva Pharmaceuticals International GmbH et al.
Counsel
Sterling, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →